The Institute for Healthcare Improvement (IHI), an independent not-for-profit organization based in Boston, Massachusetts, is a leading innovator, convener, partner, and driver of results in health and health care improvement worldwide. At our core, we believe everyone should get the best care and health possible. This passionate belief fuels our mission to improve health and health care.
Episodes
Friday Aug 10, 2018
Author in the Room: Gastric Acid-Suppressive Agents and C. difficile Risk
Friday Aug 10, 2018
Friday Aug 10, 2018
January 2006 Author in the Room® Teleconference
Author: Sandra Dial, MD, MSc
Summary Points:
- Acid suppressive therapy use was associated with an increased risk of community-acquired Clostridium difficile-associated disease (CDAD), with PPIs appearing to be associated with a higher risk than H2 blockers. These agents, particularly PPIs, are being prescribed with increasing frequency to patients, including situations where the benefits may be small.
- Although the rate is lower than in the hospital, CDAD is occurring in the community and is being diagnosed more frequently.
- Prior antibiotic exposure appears to be less frequent in patients diagnosed in the community as compared to patients diagnosed in hospital.
Version: 20241125
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.